It has been proposed that the JAK/STAT signaling pathway is involved in the development of UCEC, and targeted inhibition of the IL‐6 receptor and its downstream effectors JAK1 and STAT3 significantly reduces UCEC tumor cell growth.23 Here, JAK1 is linked to neoplasm.